Phase i study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: A national cancer institute organ dysfunction working group study

Stephen I. Shibata, Vincent Chung, Timothy W. Synold, Jeffrey A. Longmate, A. Benjamin Suttle, Lone H. Ottesen, Heinz Josef Lenz, Shivaani Kummar, R. Donald Harvey, Anne L. Hamilton, Bert H. O'Neil, John Sarantopoulos, Patricia LoRusso, Michelle A. Rudek, Afshin Dowlati, Daniel L. Mulkerin, Chandra P. Belani Leena Gandhi, S. Cecilia Lau, S. Percy Ivy, Edward M. Newman

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: A national cancer institute organ dysfunction working group study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry

Biochemistry, Genetics and Molecular Biology

Veterinary Science and Veterinary Medicine